Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CERBERO: Gut Microbiome and Immune System Dynamics During Immunotherapy in Cancer
NCT07815873Not yet recruiting
- Sponsor
- European Institute of Oncology
- Start
- Nov 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Single-arm trial in non-small cell lung cancer (NSCLC), melanoma, endometrial cancer (EC) and 1 more, sponsored by European Institute of Oncology. Planned start Nov 2026; status: not yet recruiting.
02
Conditions
non-small cell lung cancer (NSCLC)melanomaendometrial cancer (EC)Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07815873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07815873.